- Home
- SRFM vs MDCX Comparison
SRFM vs MDCX Comparison
Compare SRFM & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- MDCX
- Stock Information
- Founded
- SRFM 2011
- MDCX 2008
- Country
- SRFM United States
- MDCX Canada
- Employees
- SRFM N/A
- MDCX N/A
- Industry
- SRFM Transportation Services
- MDCX
- Sector
- SRFM Consumer Discretionary
- MDCX
- Exchange
- SRFM Nasdaq
- MDCX Nasdaq
- Market Cap
- SRFM 58.2M
- MDCX 48.4M
- IPO Year
- SRFM 2023
- MDCX N/A
- Fundamental
- Price
- SRFM $2.68
- MDCX $4.59
- Analyst Decision
- SRFM Strong Buy
- MDCX Strong Buy
- Analyst Count
- SRFM 3
- MDCX 2
- Target Price
- SRFM $6.02
- MDCX $17.00
- AVG Volume (30 Days)
- SRFM 95.8K
- MDCX 56.7K
- Earning Date
- SRFM 05-13-2025
- MDCX 01-01-0001
- Dividend Yield
- SRFM N/A
- MDCX N/A
- EPS Growth
- SRFM N/A
- MDCX N/A
- EPS
- SRFM N/A
- MDCX N/A
- Revenue
- SRFM $119,425,000.00
- MDCX N/A
- Revenue This Year
- SRFM N/A
- MDCX N/A
- Revenue Next Year
- SRFM $45.73
- MDCX N/A
- P/E Ratio
- SRFM N/A
- MDCX N/A
- Revenue Growth
- SRFM 97.38
- MDCX N/A
- 52 Week Low
- SRFM $0.90
- MDCX $1.80
- 52 Week High
- SRFM $6.72
- MDCX $4.99
- Technical
- Relative Strength Index (RSI)
- SRFM 52.36
- MDCX N/A
- Support Level
- SRFM $2.34
- MDCX N/A
- Resistance Level
- SRFM $2.55
- MDCX N/A
- Average True Range (ATR)
- SRFM 0.15
- MDCX 0.00
- MACD
- SRFM 0.06
- MDCX 0.00
- Stochastic Oscillator
- SRFM 82.35
- MDCX 0.00
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.